1981
DOI: 10.1073/pnas.78.10.6531
|View full text |Cite
|
Sign up to set email alerts
|

Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
42
0

Year Published

1982
1982
2003
2003

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 105 publications
(45 citation statements)
references
References 30 publications
3
42
0
Order By: Relevance
“…It was demonstrated that dopamine both inhibits adenylate cyclase activity and reduces the intracellular content of cyclic AMP in pituitary cells (De Camilli et al 1979;Onali et al 1981;Enjalbert & Bockaert, 1983). In the experiments designed to test the role of cyclic AMP in mediating the changes in Rb+ efflux induced by dopamine, cells were exposed to the adenylate cyclase activator forskolin.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It was demonstrated that dopamine both inhibits adenylate cyclase activity and reduces the intracellular content of cyclic AMP in pituitary cells (De Camilli et al 1979;Onali et al 1981;Enjalbert & Bockaert, 1983). In the experiments designed to test the role of cyclic AMP in mediating the changes in Rb+ efflux induced by dopamine, cells were exposed to the adenylate cyclase activator forskolin.…”
Section: Discussionmentioning
confidence: 99%
“…The intracellular mechanism involved in inhibiting both basal and stimulus-evoked hormone release is still not entirely known. Various groups of investigators have independently provided evidence that dopamine and dopaminergic agonists acting on D2 dopamine receptors can inhibit adenylate cyclase activity (De Camilli, Macconi & Spada, 1979;Onali, Schwartz & Costa, 1981;Weiss, Sebben, Garcia-Sainz, Bockaert, 1985). Recently we have found that dopamine was able to prevent both basal and neurotensin-stimulated Ca2+ influx into pituitary cells by stimulating a D2 receptor which appears to be uncoupled to adenylate cyclase (Memo, Carboni, Trabucchi, Carruba & Spano, 1985;Memo, Castelletti, Missale, Valerio, Carruba & Spano, 1986 a).…”
Section: Introductionmentioning
confidence: 99%
“…This latter difference may be due to differential coupling to adenylate cyclase for the GPCRs studied and consequent downstream actions on PKA. For example, the D2 and CB1 receptors, which activate G i/o -type G proteins, have been found to be negatively coupled to adenylyl cyclase (Howlett 1984;Howlett and Fleming 1984;Onali et al 1981)-reducing cAMP levels-whereas the G s -activating adenosine A2 receptor is positively coupled to adenylyl cyclase (van Calker et al 1979). Consistent with these findings, both CB1 and D2 effects on I Ca were mimicked by PKA inhibitor Rp-cAMPS, and the D2 effect occluded by PKA activator Sp-cAMPS (Stella and Thoreson 2000), whereas the A2 effect was occluded by RpcAMPS (Stella et al 2002).…”
Section: Mechanism Of Actionmentioning
confidence: 99%
“…Several lines of evidence indicate that the stimulatory effect of VIP on PRL release is mediated by cAMP. VIP has been shown to increase cAMP accumulation in intact pituitary cells 111, 21] and to stimulate adenylate cyclase activity in anterior pituitary membrane [18]. Moreover, it has been demonstrated that in pituitary tumor cells as well as in brain VIP stimulates the accumulation of cAMP in a Ca2+-dependent manner [2,9].…”
mentioning
confidence: 99%